Sofia Heyman
YOU?
Author Swipe
View article: Perception of cure and quality of life in anal cancer survivors
Perception of cure and quality of life in anal cancer survivors Open
Background and purpose: Anal cancer is treated with chemoradiotherapy and with salvage surgery in case of local failure. Curation rate depends on tumour stage but is overall high (80–90%). This study explored anal cancer survivors’ percept…
View article: Clinical characteristics and treatment outcome in p16 negative anal cancer
Clinical characteristics and treatment outcome in p16 negative anal cancer Open
Background: Anal squamous cell carcinoma (ASCC) is linked to human papillomavirus infection with p16 being positive in about 85% of cases. Overall survival (OS) of ASCC is 60%–80%. Prognosis in p16 negative (p16-) ASCC is worse with an OS …
View article: Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals
Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals Open
Background: Anal squamous cell cancer (ASCC) in early stages (T1–2N0M0) is treated with chemoradiotherapy with a 3-year overall survival (OS) exceeding 90%. In Swedish guidelines, it has been optional to include the external iliac and pres…
View article: Development of a consensus-based delineation guideline for locally recurrent rectal cancer
Development of a consensus-based delineation guideline for locally recurrent rectal cancer Open
This study provides a first consensus-based delineation guideline for LRRC. Analyses of re-recurrences is needed to understand disease behaviour and to optimize delineation guidelines accordingly.